Lung cancer screening programs that utilize standardized reporting and include cardiothoracic surgeons as part of a multidisciplinary team can successfully be adopted into clinical practice without an ...

Median Technologies (FR0011049824, ALMDT, "Median" or the "Company"), developer of eyonis®, a suite of artificial intelligence (AI)-powered Software as Medical Devices (SaMDs) for early cancer ...

Most high-risk lung cancer patients might not need annual low-dose computed tomography (LDCT) screenings if they are cleared of disease in their initial test, according to a study led by a Duke Cancer ...

Low-dose computed tomography (LDCT), a technique that uses X-rays to create detailed images of the lungs, has shown efficacy in diagnosing high-risk individuals, including older adults and smokers.

The STAMPEDE2 trial: A site survey of current patterns of care, access to imaging, and treatment of metastatic prostrate cancer in Nigeria. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

A secondary analysis of the National Lung Screening Trial (NLST) has found that low-dose (LDCT) lung cancer screening is actually more effective for older high-risk patients than it is for younger ...

Lung cancer cases are rising among younger, nonsmoking populations, particularly in Asia. One-time screening in a study from China led to biopsy-proven lung cancer diagnosis in 1.7% of an all-comer ...

Lung cancer remains one of the deadliest cancers, responsible for 1 in 4 cancer deaths in the US. Historically, it has been one of the most difficult to manage and cure. However, “the research story ...

Short-interval CT demonstrated spontaneous resolution of consolidation in more than 50% of lung cancer screening participants, while persistent consolidation showed a 29.8% risk for malignancy. This ...

Shira Boehler shares her journey being diagnosed with Stage 1 lung cancer. A doctor explains the need for better lung cancer screening for asymptomatic, never smokers.